Navigation Links
Alkermes in Medical News

Weekly Drug Helps Type 2 Diabetics

...aceuticals Inc., the maker of Byetta, is working with Eli Lilly and Co. and alkermes Inc. to develop exenatide once weekly. More than 21 million people in th... SOURCE: Amylin Pharmaceuticals Inc., Eli Lilly and Co., alkermes Inc., news release, June 9, 2008 ...

Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy

...nhaled insulin program. A two-year safety trial and other studies are ongoing for both the inhaled insulin formulation and device. Lilly and alkermes currently expect regulatory submission to the FDA in 2009. -- Arzoxifene - A Phase III osteoporosis prevention trial that enrolled over 30...

Once-Weekly Exenatide Showed Statistical Superiority in Glucose Control Compared to BYETTA in Head-to-Head Study

... http://www.BYETTA.com . About Amylin, Lilly, and alkermes Amylin, Lilly, and alkermes are working together to develop exenatide long-act...mprove the lives of patients with serious disease. alkermes currently has two commercial products: RISPERDAL(R...

Drug Approved to Curb Alcohol Dependency

...rs while acamprosate has its effect on a neurotransmitter. They both have been approved by Food and Drug Administration approval. Naltrexone, made by alkermes Inc. as an injectable form, to be taken monthly, will be marketed by Cephalon Inc. The results of the study have been published in the Journal o...

Alcoholism Drug Vivitrol Approved By FDA

...ypersensitivity to naltrexone, PLG or any other components of the diluent," alkermes and Cephalon said in a statement. Patients must be opioid free for at least...hould be monitored for the development of depression or suicidal thinking," alkermes and Cephalon said. Some 18 million Americans abuse or are dependent o...
Alkermes in Medical Technology

Exenatide Once Weekly Provided Superior Glucose Control Compared to Lantus(R) in Head-to-Head DURATION-3 Study

...control.(vi,vii) About Amylin, Lilly and alkermes Amylin, Lilly and alkermes are working together to develop exenatide once wee...abetes. Headquartered in Cambridge, Massachusetts, alkermes has research facilities in Massachusetts and a com...

Exenatide Once Weekly Provided Sustained Improvements in Glycemic Control With Weight Loss Over Two Years: DURATION-1 Interim Long-Term Data Presented at ADA 2009

... www.BYETTA.com . About Amylin, Lilly and alkermes Amylin, Lilly, and alkermes are working together to develop exenatide once wee...abetes. Headquartered in Cambridge, Massachusetts, alkermes has research facilities in Massachusetts and a com...

One Step Closer: Novel Opioid Receptor Compound in Phase I Clinical Trials

...addiction. The family of compounds was licensed to alkermes Inc., and the company identified a lead product ca...granting Massachusetts-based biotechnology company alkermes exclusive rights to a library of compounds discove...diction, pain, and other nervous system disorders. alkermes screened the library of compounds from Rensselaer ...

Exenatide Once Weekly Provided Superior Glucose Control With Weight Loss Compared to Sitagliptin or Pioglitazone in Head-to-Head DURATION-2 Study

...ic control.(vi,vii) About Amylin, Lilly and alkermes Amylin, Lilly, and alkermes are working together to develop exenatide once wee...abetes. Headquartered in Cambridge, Massachusetts, alkermes has research facilities in Massachusetts and a com...

Plans for Exenatide Once Weekly NDA Submission by End of First Half of 2009 Reaffirmed Following FDA Feedback

... www.BYETTA.com . About Amylin, Lilly and alkermes Amylin, Lilly, and alkermes are working together to develop exenatide once wee...and Annual Reports on Form 10-K. Amylin, Lilly and alkermes undertake no duty to update these forward-looking ...

After One Year, Type 2 Diabetes Patients Taking Exenatide Once Weekly Sustained Improvements in Glycemic Control and Weight; DURATION-1 Presented at ADA 2008

...://www.BYETTA.com . About Amylin, Lilly and Alkermes Amylin, Lilly, and alkermes are working together to develop exenatide once weekly, a subcutaneous injec...sorders, addiction and diabetes. Headquartered in Cambridge, Massachusetts, alkermes has research and manufacturing facilities in Massachusetts and Ohio. This...

Type 2 Diabetes Patients Taking Exenatide Once Weekly, a Phase 3 Investigational Diabetes Therapy, Showed Improvements in Glycemic Control, Weight

...://www.BYETTA.com . About Amylin, Lilly and Alkermes Amylin, Lilly, and alkermes are working together to develop exenatide once weekly, a subcutaneous injec...sorders, addiction and diabetes. Headquartered in Cambridge, Massachusetts, alkermes has research and manufacturing facilities in Massachusetts and Ohio. This...
Alkermes in Biological Technology

New Drug Application for Exenatide Once Weekly Accepted for Review by FDA

... www.BYETTA.com . About Amylin, Lilly and alkermes Amylin, Lilly, and alkermes are working together to develop exenatide once wee...abetes. Headquartered in Cambridge, Massachusetts, alkermes has research facilities in Massachusetts and a com...

Exenatide Once Weekly New Drug Application Submitted to FDA for Type 2 Diabetes

... www.BYETTA.com . About Amylin, Lilly and alkermes Amylin, Lilly, and alkermes are working together to develop exenatide once wee...abetes. Headquartered in Cambridge, Massachusetts, alkermes has research facilities in Massachusetts and a com...

Exenatide Clinical Data Analysis Shows No Increased Risk of Cardiovascular Events

... www.BYETTA.com . About Amylin, Lilly and alkermes Amylin, Lilly, and alkermes are working together to develop exenatide once wee...abetes. Headquartered in Cambridge, Massachusetts, alkermes has research facilities in Massachusetts and a com...

DOR BioPharma Appoints Brian L. Hamilton, MD, PhD as Chief Medical Officer

..., including three successful new drug applications for these products. He has worked with several pharmaceutical and biotechnology companies including alkermes in multiple therapeutic areas, including allergy, asthma, oncology, rheumatology, hematology, diagnostics, and drug delivery systems. "As I join...

Cephalon's New Product Launches Pace Record 2008 Sales

...1.0 million in 2008), charges related to the termination payment due to alkermes ($11.0 million in 2008) and related severance ($1.2 million in 2008), a...8.2 million in 2008), charges related to the termination payment due to alkermes ($11.0 million in 2008) and related severance ($1.2 million in 2008), a...

Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes

...ORPORATION (NASDAQ: ADLR ) ALEXION PHARMACEUTICALS INC. (NASDAQ: ALXN ) alkermes INC. (NASDAQ: ALKS ) ALLERGAN INC. (NYSE: AGN ) ALLOS THERAPEUTICS INC....ERS CORP (NYSE: WAT ) Add ABRAXIS BIOSCIENCE INC NEW (NASDAQ: ABII ) alkermes INC (NASDAQ: ALKS ) AMERISOURCEBERGEN CORP (NYSE: ABC ) APP PHARMACEUTI...

New MedPredict Report Suggests Market for Alcoholism Therapies is Underestimated

...and behavioral diagnostic instruments. Drugs/classes mentioned in this report: ReVia (naltrexone); Vivitrol (extended release injectable naltrexone; alkermes / Cephalon); Campral (acamprosate; Forest); Antabuse (disulfiram); gabapentin (generic); Topamax (topiramate; Ortho-McNeil); Prometa (flumazanil / gab...

Study Suggests Risperidone Long-Acting Injection Combined with Standard Treatment Helped Delay Time to Relapse in Patients with Bipolar Disorder

...and now is approved in more than 70 countries worldwide. The treatment uses alkermes proprietary Medisorb(R) technology to deliver and maintain therapeutic medi.... and Janssen-Cilag, a subsidiary of Johnson & Johnson, outside of the U.S. alkermes also developed and manufactures VIVITROL(R), marketed in the U.S. primarily...

Pearl Therapeutics Raises $15.5 Million in Private Financing

... development and commercialization of major products in his prior scientific, engineering and management roles at GlaxoWellcome, Dura Pharmaceuticals, alkermes and Nektar. "We are very pleased to have received strong support from top-tier and sophisticated biopharmaceutical investors," said Mr. Smith. "These...
Other Tags
(Date:5/29/2015)... (PRWEB) May 29, 2015 Mediaplanet has ... “beauty of protection”. Skin Health is a cross-platform ... within the markets of New York, Los Angeles, and ... 750,000 readers. Its digital counterpart will reach a national ... To read more the Skin Health campaign and Colorescience, ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 Healthpointe ... consultations with specialists, physical therapy, and injections , ... mid back and/or lower back pain, Healthpointe has ... injections for herniated discs, disc protrusions and other ... , Healthpointe’s team of renowned surgeons are ...
(Date:5/29/2015)... Dr. Rodger Murphree, author of Treating ... now offering free weekly call in teleconferences each ... to reduce symptoms associated with fibromyalgia including chronic ... fog. , To find out more about ... in teleconferences simply go to http://www.endfibronow.com ...
(Date:5/29/2015)... May 29, 2015 Healthpointe’s electromyography ... to the Los Angeles County clinics including its ... are now being offered at all Healthpointe locations ... and San Bernardino County. , As the ... send electrical impulses throughout the body and ...
(Date:5/29/2015)... 2015 This is a professional ... the Naproxen industry.The report provides a basic overview ... industry chain structure. The Naproxen market ... development trends, competitive landscape analysis, and key regions ... well as manufacturing processes and cost structures are ...
Breaking Medicine News(10 mins):Health News:Mediaplanet Launches “Skin Health” Campaign Featuring Colorescience 2Health News:Healthpointe’s Pain Management Specialists Now Providing Lumbar Epidural Injections in Los Angeles County 2Health News:Healthpointe’s Pain Management Specialists Now Providing Lumbar Epidural Injections in Los Angeles County 3Health News:Healthpointe Is Now Offering EMG and NCV Diagnostics at All Clinics throughout Southern California. 2Health News:Naproxen Market Analysis For Global & China Regions 2020 Research Forecasts 2
(Date:5/7/2015)... , May 7, 2015 ... sensors, FPC1022 and FPC1035, FPC,s smallest touch fingerprint ... are mainly considered for integration on the backside ... smartphone OEMs increased possibilities to integrate touch fingerprint ... size also improves possibilities for module manufacturers to ...
(Date:4/27/2015)... 27, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... focused on the growing mobile commerce market, announces that ... customers the first week of May, 2015 and will ... May. Gino Pereira , Chief ... the company as Wocket® enters the consumer market. We ...
(Date:4/20/2015)... The announcement comes as demand ... Management (GRM), Ireland,s foremost records management ... built up an impressive track record of clients within the ... the records management sector in Dubai . ... staffbase and employ a further eight staff members at its ...
Breaking Biology News(10 mins):FPC Introduces its Smallest Touch Fingerprint Sensors to Date 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 2Glenbeigh Records Management Wins Contract With Dubai Islamic Bank 3
Other Contents